滤泡性淋巴瘤-话题@MedSci

#滤泡性淋巴瘤#

69篇内容 | 3974人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1278766, encodeId=2a1012e87669a, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#滤泡性淋巴瘤#</a>, objectTitle=Am J Hematol：BCL2突变是否导致利妥昔单抗治疗的滤泡性淋巴瘤患者预后不良？, objectType=article, longId=100766, objectId=a2e7100e6654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2e7100e6654, replyNumber=0, likeNumber=81, createdTime=2017-06-07, rootId=0, userName=gongliu, userId=1a5a149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2e7100e6654, moduleTitle=Am J Hematol：BCL2突变是否导致利妥昔单抗治疗的滤泡性淋巴瘤患者预后不良？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2e7100e6654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278765, encodeId=48f512e876571, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#滤泡性淋巴瘤#</a>, objectTitle=PLoS Med：科学家深入剖析滤泡性淋巴瘤的发病机理, objectType=article, longId=84448, objectId=5abd8444835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5abd8444835, replyNumber=0, likeNumber=65, createdTime=2016-12-17, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5abd8444835, moduleTitle=PLoS Med：科学家深入剖析滤泡性淋巴瘤的发病机理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5abd8444835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278764, encodeId=024e12e876409, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#滤泡性淋巴瘤#</a>, objectTitle=Cell：CAR-T细胞免疫治疗有望攻克滤泡性淋巴瘤, objectType=article, longId=79404, objectId=3433e9404ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3433e9404ae, replyNumber=0, likeNumber=74, createdTime=2016-10-08, rootId=0, userName=gongliu, userId=1a5a149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3433e9404ae, moduleTitle=Cell：CAR-T细胞免疫治疗有望攻克滤泡性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3433e9404ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278763, encodeId=a7e512e87632e, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#滤泡性淋巴瘤#</a>, objectTitle=2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布, objectType=article, longId=78484, objectId=c96ee84848f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c96ee84848f, replyNumber=0, likeNumber=67, createdTime=2016-09-28, rootId=0, userName=gongliu, userId=1a5a149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c96ee84848f, moduleTitle=2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c96ee84848f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278762, encodeId=fb5a12e8762be, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#滤泡性淋巴瘤#</a>, objectTitle=BMJ：罕见滤泡性淋巴瘤侵犯皮肤病例报道, objectType=article, longId=58480, objectId=eedf58480a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eedf58480a9, replyNumber=0, likeNumber=71, createdTime=2015-11-09, rootId=0, userName=gongliu, userId=1a5a149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eedf58480a9, moduleTitle=BMJ：罕见滤泡性淋巴瘤侵犯皮肤病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eedf58480a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278761, encodeId=5fdf12e876162, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#滤泡性淋巴瘤#</a>, objectTitle=J Clin Oncol：来那度胺+利妥昔单抗联合治疗滤泡性淋巴瘤效果更加, objectType=article, longId=58165, objectId=68165816523, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68165816523, replyNumber=0, likeNumber=63, createdTime=2015-11-03, rootId=0, userName=gongliu, userId=1a5a149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68165816523, moduleTitle=J Clin Oncol：来那度胺+利妥昔单抗联合治疗滤泡性淋巴瘤效果更加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68165816523)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278760, encodeId=b21512e8760c7, content=<a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#滤泡性淋巴瘤#</a>, objectTitle=JCO：血清中高维生素D水平可能改善滤泡性淋巴瘤的预后, objectType=article, longId=48937, objectId=1a604893e17, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a604893e17, replyNumber=0, likeNumber=67, createdTime=2015-04-04, rootId=0, userName=gongliu, userId=1a5a149, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a604893e17, moduleTitle=JCO：血清中高维生素D水平可能改善滤泡性淋巴瘤的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a604893e17)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

滤泡性淋巴瘤

2020-05-29

gongliu (审核中...)

前往app查看评论内容

#滤泡性淋巴瘤#

Am J Hematol：BCL2突变是否导致利妥昔单抗治疗的滤泡性淋巴瘤患者预后不良？

2017-06-07

柳叶一刀 (审核中...)

前往app查看评论内容

#滤泡性淋巴瘤#

PLoS Med：科学家深入剖析滤泡性淋巴瘤的发病机理

2016-12-17

gongliu (审核中...)

前往app查看评论内容

#滤泡性淋巴瘤#

Cell：CAR-T细胞免疫治疗有望攻克滤泡性淋巴瘤

2016-10-08

gongliu (审核中...)

前往app查看评论内容

#滤泡性淋巴瘤#

2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布

2016-09-28

gongliu (审核中...)

前往app查看评论内容

#滤泡性淋巴瘤#

BMJ：罕见滤泡性淋巴瘤侵犯皮肤病例报道

2015-11-09

gongliu (审核中...)

前往app查看评论内容

#滤泡性淋巴瘤#

J Clin Oncol：来那度胺+利妥昔单抗联合治疗滤泡性淋巴瘤效果更加

2015-11-03

gongliu (审核中...)

前往app查看评论内容

#滤泡性淋巴瘤#

JCO：血清中高维生素D水平可能改善滤泡性淋巴瘤的预后

2015-04-04

科室
- - 订阅+
  - 更多科室
工具
服务